Received: 16 September 2020
Accepted: 16 September 2021
First Online: 21 October 2021
: A.T. has received grants from MedImmune, Cubist, Bayer, Theravance and Polyphor and personal fees as an advisory board member from Bayer, Roche, The Medicines CO and Curetis. He has received personal fees as a member of the speaker’s bureau from GSK, Pfizer, Astra Zeneca and Biotest Advisory Board, outside the submitted work. None of the other authors have any competing interests with the current publication.
Free to read: This content has been made available to all.